ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

Litton’s Government Contracts Status Under Review

September 6, 1985

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000